Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 227.30
DYII's Cash to Debt is ranked higher than
81% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. DYII: 227.30 )
Ranked among companies with meaningful Cash to Debt only.
DYII' s 10-Year Cash to Debt Range
Min: 0.25  Med: 8.71 Max: No Debt
Current: 227.3
Equity to Asset 0.59
DYII's Equity to Asset is ranked higher than
70% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. DYII: 0.59 )
Ranked among companies with meaningful Equity to Asset only.
DYII' s 10-Year Equity to Asset Range
Min: 0.54  Med: 0.71 Max: 0.86
Current: 0.59
0.54
0.86
F-Score: 6
Z-Score: 0.36
M-Score: -2.52
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -92.18
DYII's Operating margin (%) is ranked lower than
98% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 7.05 vs. DYII: -92.18 )
Ranked among companies with meaningful Operating margin (%) only.
DYII' s 10-Year Operating margin (%) Range
Min: -491.12  Med: 0.71 Max: 992.41
Current: -92.18
-491.12
992.41
Net-margin (%) -76.10
DYII's Net-margin (%) is ranked lower than
97% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 3.29 vs. DYII: -76.10 )
Ranked among companies with meaningful Net-margin (%) only.
DYII' s 10-Year Net-margin (%) Range
Min: -219.69  Med: 8.91 Max: 1063.02
Current: -76.1
-219.69
1063.02
ROE (%) -7.69
DYII's ROE (%) is ranked lower than
82% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 8.45 vs. DYII: -7.69 )
Ranked among companies with meaningful ROE (%) only.
DYII' s 10-Year ROE (%) Range
Min: -40.22  Med: -0.70 Max: 51.09
Current: -7.69
-40.22
51.09
ROA (%) -4.73
DYII's ROA (%) is ranked lower than
81% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 3.44 vs. DYII: -4.73 )
Ranked among companies with meaningful ROA (%) only.
DYII' s 10-Year ROA (%) Range
Min: -29.81  Med: -0.58 Max: 32.19
Current: -4.73
-29.81
32.19
ROC (Joel Greenblatt) (%) -34.60
DYII's ROC (Joel Greenblatt) (%) is ranked lower than
90% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 15.83 vs. DYII: -34.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
DYII' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -147.09  Med: -10.13 Max: 129.56
Current: -34.6
-147.09
129.56
EBITDA Growth (3Y)(%) -44.20
DYII's EBITDA Growth (3Y)(%) is ranked lower than
96% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. DYII: -44.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
DYII' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -2.40 Max: 136.6
Current: -44.2
0
136.6
EPS Growth (3Y)(%) -100.00
DYII's EPS Growth (3Y)(%) is ranked lower than
96% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. DYII: -100.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
DYII' s 10-Year EPS Growth (3Y)(%) Range
Min: -100  Med: 25.40 Max: 93.9
Current: -100
-100
93.9
» DYII's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with DYII

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.27
DYII's P/B is ranked higher than
99% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 2.73 vs. DYII: 0.27 )
Ranked among companies with meaningful P/B only.
DYII' s 10-Year P/B Range
Min: 0.01  Med: 0.61 Max: 2.3
Current: 0.27
0.01
2.3
P/S 0.23
DYII's P/S is ranked higher than
75% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. DYII: 0.23 )
Ranked among companies with meaningful P/S only.
DYII' s 10-Year P/S Range
Min: 0.01  Med: 1.31 Max: 28.5
Current: 0.23
0.01
28.5
PFCF 3.67
DYII's PFCF is ranked higher than
96% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 21.92 vs. DYII: 3.67 )
Ranked among companies with meaningful PFCF only.
DYII' s 10-Year PFCF Range
Min: 1.62  Med: 11.90 Max: 131.25
Current: 3.67
1.62
131.25
POCF 3.24
DYII's POCF is ranked higher than
95% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 15.63 vs. DYII: 3.24 )
Ranked among companies with meaningful POCF only.
DYII' s 10-Year POCF Range
Min: 1.55  Med: 6.77 Max: 18.92
Current: 3.24
1.55
18.92
EV-to-EBIT 2.78
DYII's EV-to-EBIT is ranked higher than
99% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 20.07 vs. DYII: 2.78 )
Ranked among companies with meaningful EV-to-EBIT only.
DYII' s 10-Year EV-to-EBIT Range
Min: -31  Med: -0.10 Max: 31.2
Current: 2.78
-31
31.2
Current Ratio 1.02
DYII's Current Ratio is ranked lower than
65% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. DYII: 1.02 )
Ranked among companies with meaningful Current Ratio only.
DYII' s 10-Year Current Ratio Range
Min: 1.02  Med: 1.64 Max: 6.23
Current: 1.02
1.02
6.23
Quick Ratio 1.00
DYII's Quick Ratio is ranked lower than
60% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. DYII: 1.00 )
Ranked among companies with meaningful Quick Ratio only.
DYII' s 10-Year Quick Ratio Range
Min: 1  Med: 1.62 Max: 6.22
Current: 1
1
6.22
Days Inventory 168.81
DYII's Days Inventory is ranked lower than
95% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 17.87 vs. DYII: 168.81 )
Ranked among companies with meaningful Days Inventory only.
DYII' s 10-Year Days Inventory Range
Min: 10.31  Med: 34.16 Max: 112.33
Current: 168.81
10.31
112.33
Days Sales Outstanding 243.46
DYII's Days Sales Outstanding is ranked lower than
97% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 46.60 vs. DYII: 243.46 )
Ranked among companies with meaningful Days Sales Outstanding only.
DYII' s 10-Year Days Sales Outstanding Range
Min: 52.66  Med: 92.09 Max: 1478.93
Current: 243.46
52.66
1478.93

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 16.00
DYII's Price/Net Current Asset Value is ranked lower than
616% of the 49 Companies
in the Global Medical Care industry.

( Industry Median: 12.33 vs. DYII: 16.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
DYII' s 10-Year Price/Net Current Asset Value Range
Min: 0.12  Med: 2.06 Max: 41.71
Current: 16
0.12
41.71
Price/Tangible Book 0.08
DYII's Price/Tangible Book is ranked higher than
99% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. DYII: 0.08 )
Ranked among companies with meaningful Price/Tangible Book only.
DYII' s 10-Year Price/Tangible Book Range
Min: 0.02  Med: 1.39 Max: 7.11
Current: 0.08
0.02
7.11
Price/Median PS Value 0.17
DYII's Price/Median PS Value is ranked lower than
160% of the 189 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. DYII: 0.17 )
Ranked among companies with meaningful Price/Median PS Value only.
DYII' s 10-Year Price/Median PS Value Range
Min: 0.05  Med: 1.73 Max: 19
Current: 0.17
0.05
19
Earnings Yield (Greenblatt) (%) 36.00
DYII's Earnings Yield (Greenblatt) (%) is ranked higher than
100% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. DYII: 36.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
DYII' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.2  Med: 59.80 Max: 2209.4
Current: 36
3.2
2209.4

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Dynacq Healthcare, Inc. was incorporated in Nevada in February 1992. The Company was reincorporated in Delaware in November 2003 and reincorporated back in Nevada in August 2007. The Company is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings. The Company's hospital, Surgery Specialty Hospitals of America - Southeast Houston Campus in Pasadena, Texas, near Houston (the Pasadena facility), includes operating rooms, pre- and post-operative space, intensive care units, nursing units and diagnostic facilities, as well as adjacent medical office buildings. The Company operates in the greater Houston, Texas market. In the United States, the Company manages and operates one general acute care hospital that principally provides specialized surgeries such as bariatric, orthopedic and neuro-spine surgeries. The Company competes with other providers, including major acute care hospitals. It also encounters competition with other companies for strategic relationships with physicians. The Company complies with government regulation at the federal, state and local levels.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK